Produktbeschreibung
Doxorubicinhydrochlorid-Liposom-Injektion can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients. Doxorubicinhydrochlorid-Liposom-Injektion can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients: vincristine, bleomycin and doxorubicin.
Arzneimittelname
Gattungsbezeichnung. Doxorubicinhydrochlorid-Liposom-InjektionAbschnitt
English Name. Doxorubicin Hydrochloride Liposome Injection
Molecular Formular. C27H29NO11 HCl
Molekulargewicht. 579,99
Doxorubicinhydrochlorid-Liposom-Injektion Beschreibung
This product is red semitransparent mixed suspension.
Doxorubicinhydrochlorid-Liposom-Injektion Indikationen
1. This product can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients.
2. This product can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients:vincristine, bleomycin and doxorubicin (or other anthracycline Antibiotika).
Spezifikation
20 mg/10 ml
Verpackung
1 Flasche/Karton
Vorbereitungen
Injektion
